Navigation Links
Monitorforhire.com Adds Mobile Phone Capability Further Speeding Access to Experienced Monitors
Date:10/2/2007

CONSHOHOCKEN, Pa., Oct. 2 /PRNewswire/ -- Monitorforhire.com, the fastest source for hiring independent clinical monitors, has made its service even faster. The company has added a mobile portal, enabling registered monitors to receive and respond immediately to work requests via PDA or cell phone using http://www.monitorforhire.com/mobile.

Scott Freedman, president of monitorforhire.com says that adding the capability will further reduce response times, enabling sponsors to staff their trials more quickly.

"We've enhanced a well proven model, by making it a true on-demand system for contacting and hiring clinical monitors," Freedman said. "By adding mobile phone and PDA access, we have real-time capability to instantly connect and staff trials in 36 hours or less."

Time lost organizing and conducting clinical trials can be costly. Current estimates of the cost of bringing a new drug to market range from nearly $900 million to over $1.7 billion. Goldman Sachs predicts that pharmaceutical R&D spending will increase seven percent per year from 2004 to 2009, due in part to longer R&D timelines needed to bring new drugs to market.

"Sponsors are looking for solutions that help them speed the process of bringing new drugs to market," Freedman said. "This is one more way that monitorforhire.com is helping them to do this."

Founded in 2000, monitorforhire.com is the only Web-based service for clinical trial sponsors in biotechnology, pharmaceutical, medical device and contract research organizations to instantly connect with thousand of qualified, independent clinical monitors in a variety of therapeutic specialties. Today, the company has a network of more than 2,560 pre-qualified monitors in 33 countries. More than 564 clinical trial sponsors are currently registered. For further information, please visit monitorforhire.com or call 610-862-0909.


'/>"/>
SOURCE monitorforhire.com
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Mobile Phase Optimization for the Analysis of an Antibody-Based Fusion Protein and Aggregates using a TSKgel Super SW3000 Size-Exclusion Column
2. Security concerns grow with mobile tech devices
3. Am I spoiled if I expect well-designed mobile devices?
4. Webaroo aims to make mobile search relevant
5. Will mobile phones go back to school?
6. GE Healthcare, MobileAccess to collaborate on hospital wireless
7. GE Healthcare releases new mobile computing capabilities for physicians
8. MobilePro to aquire Janesville-based internet service provider
9. Mobile content: Where brand meets markets
10. ADC and Network365 Team to Offer New End-to-End Mobile Payment System
11. The News From DEMOmobile 2003
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Fla. , Feb. 16, 2017  MDNA ... revolutionizing the development of liquid biopsy tests based ... entered into an exclusive license agreement with its ... MDNA,s proprietary liquid biopsy test for prostate cancer, ... South Korea . This is the first ...
(Date:2/16/2017)... Mass. , Feb. 16, 2017   Biostage, ... the "Company"), a biotechnology company developing bioengineered organ implants ... esophagus, bronchus and trachea, announced today the closing on ... of 20,000,000 shares of common stock and warrants to ... proceeds of $8.0 million. The offering was priced at ...
(Date:2/16/2017)... Feb. 16, 2017  Champions Oncology, Inc. (NASDAQ: ... and sale of advanced technology solutions and products to ... announced the addition of new cohorts of PDX models ... models will expand Champions, product line in hepatocellular cancer, ... cancer, AML, and non-small cell lung cancer (including EGFR ...
(Date:2/16/2017)... and NEW YORK , Feb. ... near completion of their $7M Series B financing, adding ... of the $3.5M led by Mesa Verde Venture Partners ... These resources will be directed towards further accelerating commercial ... a comprehensive genomic profiling test and expanding the Paradigm ...
Breaking Biology Technology:
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
Breaking Biology News(10 mins):